###begin article-title 0
###xml 73 78 <span type="species:ncbi:9606">Human</span>
Full-Exon Resequencing Reveals Toll-Like Receptor Variants Contribute to Human Susceptibility to Tuberculosis Disease
###end article-title 0
###begin p 1
Conceived and designed the experiments: YL BG JM. Performed the experiments: XM YL BG. Analyzed the data: AC XM YL BG JM EG. Contributed reagents/materials/analysis tools: AC EG. Wrote the paper: XM. Other: Contributed equally to this work: AC EG.
###end p 1
###begin p 2
Current address: Department of Pathology, University of Washington, Seattle, Washington, United States of America,
###end p 2
###begin p 3
Current address: Institute for Antiviral Research, Utah State University, Logan, Utah, United States of America
###end p 3
###begin p 4
###xml 856 871 856 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6-TLR1-TLR10</italic>
###xml 1028 1043 1028 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6-TLR1-TLR10</italic>
###xml 152 157 <span type="species:ncbi:9606">human</span>
###xml 322 327 <span type="species:ncbi:10090">mouse</span>
###xml 376 381 <span type="species:ncbi:9606">human</span>
###xml 394 399 <span type="species:ncbi:9606">Human</span>
###xml 684 692 <span type="species:ncbi:9606">patients</span>
###xml 1410 1418 <span type="species:ncbi:9606">children</span>
###xml 1755 1760 <span type="species:ncbi:9606">human</span>
###xml 1833 1838 <span type="species:ncbi:9606">human</span>
###xml 1971 1976 <span type="species:ncbi:9606">human</span>
Tuberculosis (TB) is the leading cause of death worldwide due to an infectious agent. Data have accumulated over decades suggesting that variability in human susceptibility to TB disease has a genetic component. Toll-like receptors (TLRs) play a critical role in initiating the innate immune response to many pathogens in mouse models, but little is known about their role in human infections. Human TLRs have been reported to recognize mycobacterial antigens and initiate an immune response. We tested the hypothesis that amino acid-altering polymorphisms in five TLRs were associated with susceptibility to TB disease using a population-based case-control study with 1,312 adult TB patients and controls. Full-coding region sequencing of the five TLR genes in all 1,312 subjects yielded a data set in excess of 16 Mb. Rare nonsynonymous polymorphisms in TLR6-TLR1-TLR10 were significantly overrepresented among African-American TB cases compared with ethnically-matched control subjects. Common nonsynonymous polymorphisms in TLR6-TLR1-TLR10 also were significantly associated with TB disease in certain ethnic groups. Among African Americans, homozygotes for the common-variant haplotype TLR1-248S, TLR1-602I, and TLR6-249S had a significantly increased TB disease risk. A transmission/disequilibrium test on an independent sample found that the TLR1-248S variant was preferentially transmitted to diseased children, thereby confirming disease association. These results are consistent with recent reports implicating TLR1 variants, including TLR1-602, in significantly altered innate immune responses. Also consistent with disease association, rare TLR6 variants were defective in their ability to mediate NF-kappaB signal transduction in transfected human cells. Taken together, the data suggest that variant TLRs contribute to human susceptibility to TB disease. Extensive full-exon resequencing was critical for revealing new information about the role of TLRs in human-pathogen interactions and the genetic basis of innate immune function.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 51 77 51 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 166 169 166 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-World1">[1]</xref>
###xml 51 77 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 79 82 <span type="species:ncbi:1773">MTB</span>
###xml 368 371 <span type="species:ncbi:1773">MTB</span>
Tuberculosis (TB), an infectious disease caused by Mycobacterium tuberculosis (MTB), is a leading public health problem in the United States and throughout the world [1]. Development of active TB disease depends on a complex relationship between the bacterium and the host. Importantly, only about 10% of presumed immunologically normal individuals who are exposed to MTB will develop disease in their lifetime. The molecular mechanisms responsible for susceptibility to clinical disease caused by this pathogen are poorly understood.
###end p 6
###begin p 7
###xml 138 141 138 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Kallman1">[2]</xref>
###xml 142 145 142 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Remus1">[6]</xref>
###xml 270 273 270 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Kallman1">[2]</xref>
###xml 275 278 275 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Comstock1">[3]</xref>
###xml 395 398 395 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Casanova1">[4]</xref>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Khor1">[14]</xref>
###xml 760 763 756 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Casanova1">[4]</xref>
###xml 764 768 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Khor1">[14]</xref>
###xml 87 93 <span type="species:ncbi:9606">humans</span>
###xml 134 137 <span type="species:ncbi:1773">MTB</span>
Many lines of evidence suggest that host genetics contributes to the susceptibility of humans to developing disease after exposure to MTB [2]-[6]. Familial occurrence, and higher rates of TB disease concordance among monozygotic than dizygotic twins, have been reported [2], [3]. In addition, studies have identified associations between polymorphisms in several candidate genes and clinical TB [4]-[14]. For example, alleles of genes encoding HLA class II antigens, mannose-binding protein, natural resistance-associated macrophage protein 1 (NRAMP1), vitamin D-receptor, interleukin-1 (IL-1), IL-1 receptor, IL-8, IL-12 receptor, MCP-1, DC-SIGN, SP110, TIRAP, MAL, and interferon-gamma have been reported to be associated with TB disease in some populations [4]-[14]. However, with few exceptions, the disease-associated alleles reported in these studies have only relatively modest effects, suggesting that additional susceptibility genes remain to be discovered.
###end p 7
###begin p 8
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Akira1">[15]</xref>
###xml 427 431 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Akira1">[15]</xref>
###xml 744 748 736 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Tapping1">[16]</xref>
###xml 784 789 776 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 791 795 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Arbour1">[17]</xref>
###xml 1093 1097 1085 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Akira1">[15]</xref>
###xml 1197 1201 1189 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Smirnova1">[18]</xref>
###xml 1202 1206 1194 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Johnson1">[21]</xref>
###xml 1457 1460 1449 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 922 928 <span type="species:ncbi:9606">humans</span>
###xml 940 945 <span type="species:ncbi:9606">human</span>
###xml 1362 1369 <span type="species:ncbi:9606">patient</span>
Toll-like receptors (TLRs) are a family of proteins that play a key role in the innate immune response to infectious agents through their ability to discriminate conserved microbial structures, known as pathogen-associated molecular patterns (PAMPs), from self [15]. TLR recognition of PAMPs such as lipopolysaccharide (LPS), teichoic acid, and surface lipoproteins, initiates signal transduction through the NF-kappaB pathway [15]. Nuclear translocation of NF-kappaB induces transcription of proinflammatory cytokine genes essential to mounting a protective immune response and host defense. Different TLRs recognize distinct classes of products synthesized by pathogens. For example, TLR4 is a receptor for LPS made by Gram-negative bacteria [16]. Consistent with this role, Arbour et al. [17] reported that amino acid polymorphisms in the extracellular domain of TLR4 conferred altered responsiveness to inhaled LPS in humans. Among the human TLR family members described to date, TLR1, TLR2, TLR3, TLR4, TLR5, TLR6, and TLR9 have been implicated in the recognition of bacterial components [15]. Associations between TLR polymorphisms and susceptibility to infectious agents have been reported [18]-[21]. However, the conclusions that can be drawn from these studies are limited because, in general, relatively few polymorphic sites have been analyzed, small patient populations have been studied, and the analyses have largely been confined to a single TLR gene.
###end p 8
###begin p 9
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Underhill1">[22]</xref>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Hawn3">[34]</xref>
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Drennan1">[28]</xref>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Uehori1">[35]</xref>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Ogus1">[36]</xref>
###xml 403 407 403 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-BenAli1">[37]</xref>
###xml 477 480 477 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 643 647 643 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR1</italic>
###xml 649 653 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 655 659 655 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 661 665 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 671 676 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR10</italic>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 131 137 <span type="species:ncbi:9606">humans</span>
###xml 447 452 <span type="species:ncbi:9606">human</span>
###xml 453 461 <span type="species:ncbi:9606">patients</span>
###xml 588 593 <span type="species:ncbi:9606">human</span>
###xml 766 772 <span type="species:ncbi:9606">humans</span>
TLRs have been reported to participate in the interaction of pathogenic mycobacteria or their extracellular products with mice and humans [22]-[34]. In particular, TLR2 in association with TLR1 and TLR6, and TLR4 have been implicated as receptors involved in the recognition of mycobacterial antigens and activation of macrophages and dendritic cells (DCs) [28]-[35]. However, with few exceptions [36], [37] there has been little investigation in human patients of the role of TLR polymorphisms in susceptibility to TB disease, reflecting a general lack of understanding of this topic in human infections. Here we used full-exon sequencing of TLR1, TLR2, TLR4, TLR6, and TLR10 to test the hypothesis that TLR variants are significantly associated with TB disease in humans.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
Overview of Sequence Variation in the TLRs
###end title 11
###begin p 12
###xml 65 68 65 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 393 402 393 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001318-g001">Figure 1B</xref>
###xml 407 415 407 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001318.s002">Table S1</xref>
###xml 435 438 435 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 607 611 607 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Yu1">[38]</xref>
###xml 747 751 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Yu1">[38]</xref>
###xml 939 943 939 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Yu1">[38]</xref>
###xml 1112 1121 1112 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001318-g001">Figure 1B</xref>
###xml 1126 1134 1126 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001318.s002">Table S1</xref>
###xml 910 915 <span type="species:ncbi:9606">human</span>
Analysis of sequence variation in the coding regions of the five TLRs in the 1,312 subjects from three ethnicities (African American, European American, and Hispanic) identified 179 sequence variants including 126 nonsynonymous polymorphisms (NSP, altering the primary amino acid sequence) and 53 synonymous single nucleotide polymorphisms (sSNPs, not resulting in an amino acid replacement) (Figure 1B and Table S1). On average, each TLR had 25 NSPs (range 23-30 variants), and 10 sSNPs (range 7-18). Thus, NSPs were more abundant than sSNPs by a ratio of 2.5:1, a larger number than is typically observed [38]. Most polymorphic sites were single nucleotide polymorphisms (SNP; 174/179 variants), reflecting lower than average indel polymorphism [38]. Transition substitutions were more prevalent (130/174; 74.7%) than transversions (44/174; 25.3%) among these SNPs, a result consistent with other studies of human DNA sequence variation [38]. Among the nonsynonymous differences are included four rare deletions (1-5 bp in length), one insertion (1-bp), and six nonsense variants (SNPs generating stop codon) (Figure 1B and Table S1).
###end p 12
###begin title 13
Schematic of the TLR proteins and sequence variants.
###end title 13
###begin p 14
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 68 69 68 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 218 226 <span type="species:ncbi:9606">patients</span>
(A) Schematic of human chromosome 4 showing location of TLR genes. (B) Summary of variants identified in five TLR proteins. Shown are all variant sites that would be made by the TLR alleles identified in either the TB patients or control subjects. Black, rare variant; red, variants that are common in all three ethnic groups analyzed. SG, signal peptide; TM, transmembrane domain; TIR, Toll/IL-1 receptor domain; NSP, nonsynonymous polymorphisms (includes nonsynonymous single nucleotide polymorphisms, nonsense mutations, and insertion and deletions). Numbers in parentheses denote amino acid residue positions.
###end p 14
###begin p 15
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR1</italic>
###xml 172 176 172 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 245 250 245 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR10</italic>
###xml 463 472 463 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001318-g001">Figure 1B</xref>
###xml 477 485 477 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001318.s002">Table S1</xref>
###xml 617 624 617 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001318-t001">Table 1</xref>
The proportion of amino acid residues that have a nonsynonymous polymorphism among the five target genes was very similar, being 3.1% in TLR1 (24/786 amino acids), 2.9% in TLR2 (23/784), 3.6% in TLR4 (30/839), 3.0% in TLR6 (24/796), and 3.1% in TLR10 (25/811). Twenty-four of the NSPs were present in all three ethnic groups, 22 in two ethnic groups, and 80 NSPs were found in only one ethnic group, of which 53 NSPs presented only once in one single individual (Figure 1B and Table S1). No significant variation was observed among the three ethnic groups in the frequency of occurrence of unique NSP per individual (Table 1).
###end p 15
###begin title 16
###xml 64 67 64 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 58 63 <span type="species:ncbi:9606">human</span>
Distribution of common and rare nonsynonymous variants of human TLR genes among different ethnic groups.
###end title 16
###begin p 17
Number show the number of nonsynonymous common/rare variants in the target genes based on a cutoff line of allelic frequency 0.03 for common and rare variants in each single ethnicity. NSPs, nonsynonymous polymorphisms.
###end p 17
###begin p 18
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR1</italic>
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 56 61 56 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR10</italic>
###xml 96 111 96 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6-TLR1-TLR10</italic>
###xml 176 185 176 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001318-g001">Figure 1A</xref>
###xml 875 890 875 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6-TLR1-TLR10</italic>
Four of the five TLRs we studied (TLR1, TLR2, TLR6, and TLR10) are encoded by chromosome 4, and TLR6-TLR1-TLR10 comprises a gene cluster located within a 54-kb region of 4p14 (Figure 1A). TLR1 and TLR6 share 69% amino acid sequence identity, TLR1 and TLR10 have 49% sequence identity, and TLR6 and TLR10 have 47% sequence identity. In contrast, TLR2 and TLR4 have much lower identity with each other and other TLRs (range, 20%-30%). Alignment of TLR1, TLR6, and TLR10 revealed that 20 of 73 (27.4%) NSPs were located at amino acid sites conserved among these TLRs. This result may indicate the functional importance of these rare or common NSPs. There were 39 (53.4%) NSPs at homologous residues in more than one TLR, a figure that exceeds the number expected by chance. This result suggests that intergenic gene conversion may be contributing to the variability seen in the TLR6-TLR1-TLR10 cluster.
###end p 18
###begin title 19
Genotype Distribution
###end title 19
###begin p 20
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 315 316 315 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
All polymorphic nucleotide sites present in the five TLRs were bi-allelic. Treating each polymorphic site as a locus with two alleles, we tested the hypothesis that the control subjects were taken from a population in Hardy-Weinberg equilibrium. Of the 591 single SNP tests for Hardy-Weinberg proportions, 17 had a P value less that 0.05, a figure somewhat less than expected based on chance alone. After correcting for multiple comparisons, there was no significant deviation toward an excess or deficit of expected heterozygosity (data not shown).
###end p 20
###begin title 21
###xml 17 32 17 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6-TLR1-TLR10</italic>
Rare NSPs in the TLR6-TLR1-TLR10 Gene Cluster Are Significantly Overrepresented Among African American TB Cases
###end title 21
###begin p 22
###xml 118 133 118 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6-TLR1-TLR10</italic>
###xml 510 517 508 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001318-t001">Table 1</xref>
###xml 644 648 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Smirnova1">[18]</xref>
###xml 686 689 684 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 784 791 782 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001318-t002">Table 2</xref>
###xml 916 920 914 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR1</italic>
###xml 933 934 931 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 945 949 943 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 962 963 960 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 978 983 976 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR10</italic>
###xml 996 997 994 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1008 1015 1006 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001318-t002">Table 2</xref>
###xml 1171 1176 1169 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR10</italic>
###xml 1189 1190 1187 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1214 1218 1212 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 1303 1304 1301 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1377 1381 1375 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 1470 1474 1468 1472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 1480 1484 1478 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Newport1">[39]</xref>
###xml 1557 1560 1555 1558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 33 41 <span type="species:ncbi:9606">patients</span>
###xml 606 614 <span type="species:ncbi:9606">patients</span>
We tested the hypothesis that TB patients and control subjects differed significantly in the frequency of NSPs in the TLR6-TLR1-TLR10 gene cluster. For this analysis, NSPs were divided into two groups, designated as common (allele frequency>/=3%) and rare (allele frequency<3%) NSPs. Inasmuch as polymorphisms were present at different allelic frequencies in the three ethnic groups studied, we defined each variant as rare or common based on its frequency in each ethnic group (including cases and controls) (Table 1). Due to the low allele frequencies of rare variants, and findings reported for TLR4 in patients with meningococcal infection [18], we pooled all rare NSPs within each TLR and compared the frequencies of rare alleles between cases and controls in each ethnic group (Table 2). Compared to control subjects, African American tuberculosis cases had a significantly increased frequency of rare NSPs in TLR1 (OR = 3.32; P = 0.002), TLR6 (OR = 1.85; P = 0.040), and TLR10 (OR = 1.76; P = 0.009) (Table 2). In contrast, European American cases had fewer rare NSPs in these genes (ORs<1.00) compared to the controls, but only showed statistical significance in TLR10 (OR = 0.34; P = 0.006). In addition, TLR2 had significantly more rare NSPs among Hispanic controls than the cases (OR = 0.28; P<0.001). There was no significant association found between rare NSPs in TLR4 and TB disease across three ethnic groups, a result consistent with a previous study of TLR4 SNPs [39]. Taken together, the results support the idea that rare NSPs in several TLRs are associated with altered susceptibility to TB disease. In no case was there a significant association between the count of rare synonymous SNPs and disease status.
###end p 22
###begin title 23
###xml 33 50 33 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR1, 2, 4, 6, 10</italic>
Association between rare NSPs of TLR1, 2, 4, 6, 10 and TB disease
###end title 23
###begin p 24
Number of nonsynonymous polymorphisms (NSPs) identified in each group.
###end p 24
###begin p 25
Number of alleles carrying rare nonsynonymous variants.
###end p 25
###begin p 26
###xml 20 21 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Odds ratio (OR) and P value were calculated by comparing the numbers of alleles with rare nonsynonymous variants between the cases and controls in each ethnic group.
###end p 26
###begin title 27
###xml 34 49 34 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6-TLR1-TLR10</italic>
Association of Common NSPs in the TLR6-TLR1-TLR10 Gene Cluster with TB Disease
###end title 27
###begin p 28
###xml 50 58 50 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001318.s003">Table S2</xref>
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 330 334 330 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR1</italic>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR10</italic>
###xml 463 471 463 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001318.s003">Table S2</xref>
###xml 521 525 521 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 526 530 526 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR1</italic>
###xml 531 536 531 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR10</italic>
###xml 565 570 <span type="species:ncbi:9606">human</span>
Nine NSPs were common in all three ethnic groups (Table S2). TLR2 lacked common NSP variants. Genotypic frequencies for all 21 common NSP were compared between cases and controls within corresponding ethnic groups. None of the three common NSPs in TLR4 was associated with TB disease. In contrast, 15 of the 18 common NSPs in the TLR6-TLR1-TLR10 gene cluster were significantly associated with TB disease in one or more of the ethnic groups (ORs from 1.63-6.77) (Table S2). This result provided evidence that NSPs in the TLR6-TLR1-TLR10 gene cluster contributed to human susceptibility to TB disease.
###end p 28
###begin p 29
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR1</italic>
###xml 185 193 185 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001318.s003">Table S2</xref>
###xml 1105 1106 1105 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1425 1426 1425 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1624 1628 1624 1628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Johnson1">[21]</xref>
###xml 1630 1634 1630 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Chang1">[31]</xref>
###xml 1635 1639 1635 1639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Hawn3">[34]</xref>
###xml 1799 1814 1799 1814 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 471 479 <span type="species:ncbi:9606">patients</span>
###xml 1799 1814 <span type="species:ncbi:1773">M. tuberculosis</span>
Two common TLR1 NSPs (N248S and S602I) were in linkage disequilibrium and had reciprocal allele frequencies of minor and major alleles between African Americans and European Americans (Table S2). For example, the G and A alleles of N248S had allele frequencies of 0.789 and 0.211 respectively, in African Americans compared with 0.116 and 0.884, respectively in European Americans. Alleles of both NSPs (248S and 602I) were associated with TB disease in African American patients. N248 (common in European Americans) is a conserved amino acid site in the extracellular domain of TLR1 and TLR6 (N253), and is a putative glycosylation site. Replacement of the Asn residue with Ser might result in altered glycosylation, potentially changing TLR1 folding or function (e.g., PAMP recognition or signal transduction). The S602I amino acid replacement alters the first amino acid of the inferred intracellular domain of TLR1, and this residue varies in TLR10 (L602) and TLR6 (I607). The odds ratios for the tests of association of TLR1 N248S and S602I with TB in African Americans were 1.63 and 2.50 (with tail P values of 0.009 and <0.001 respectively), whereas the respective odds ratios in European Americans were 0.20 and 0.49 (neither significant). The two-locus analysis for these SNPs however yielded odds ratios for the highest-risk genotype of 2.68 and 1.75 in African Americans and European Americans, with corresponding P-values of <0.001 and 0.007. The two-SNP haplotype contributed more to enhanced susceptibility to TB disease than did the single SNPs in our sample. These results are consistent with recent reports [21], [31]-[34] implicating TLR1 common variants such as S248N and S602I, and rare variants H305L and P315L in altered innate immune responses to lipopeptides and extracts of M. tuberculosis, and differential susceptibility to leprosy.
###end p 29
###begin title 30
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
Functional Analysis of Rare TLR6 Variants Associated with TB
###end title 30
###begin p 31
###xml 833 837 829 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Ozinsky1">[40]</xref>
###xml 1062 1066 1054 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Takeuchi1">[41]</xref>
###xml 131 136 <span type="species:ncbi:9606">human</span>
###xml 480 483 <span type="species:ncbi:1773">MTB</span>
###xml 508 513 <span type="species:ncbi:10090">mouse</span>
###xml 646 661 <span type="species:ncbi:10029">Chinese hamster</span>
###xml 685 690 <span type="species:ncbi:10090">mouse</span>
###xml 959 964 <span type="species:ncbi:9606">human</span>
The genetic epidemiology data and the population genetic analysis suggested that, as a population, rare TLR variants contribute to human susceptibility to TB disease. If this is the case, it is reasonable to expect that some of the rare TLR variants have altered function. Because it was not practical to study the functional aspects of all TLR variants, we elected to focus our efforts on several TLR6 variants. This TLR was chosen for analysis because it has been implicated in MTB-host interaction in the mouse, and reporter assays were available at the time when the nucleotide sequence data were completed. It has previously been shown with Chinese hamster ovary (CHO) cells that mouse TLR6 and TLR2 associate in a ligand-independent manner to form a functional complex that constitutively signals through the NF-kappaB pathway [40]. Similar studies conducted with HEK 293 cells demonstrated NF-kappaB activation as a consequence of the co-expression of human TLR2 and TLR6, and found that the cytoplasmic domains of these TLRs were necessary for signaling [41].
###end p 31
###begin p 32
###xml 521 525 521 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 570 574 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 803 811 791 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001318-g002">Figure 2</xref>
###xml 1038 1046 1022 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001318-g002">Figure 2</xref>
###xml 1194 1202 1178 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001318-g001">Figure 1</xref>
###xml 1261 1269 1241 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001318-g002">Figure 2</xref>
###xml 564 569 <span type="species:ncbi:9606">human</span>
Thus, we hypothesized that the TLR6 proteins resulting from rare mutations that truncate TLR6, or mutations that alter the Toll/interleukin-1 receptor (TIR) domain by a single amino acid, would be defective in signal transduction. To test this hypothesis, we generated TLR6 cDNA vectors expressing wild-type TLR6, a dominant negative form of TLR6 (Pro680His), and 5 TLR6 variants. Of the 5 rare variants examined, 2 were truncated receptors, the other two each had a single amino acid substitution in the TIR domain. The TLR6 constructs were co-transfected with a human TLR2 expression vector and an NF-kappaB reporter into HEK 293 cells and their ability to mediate NF-kappaB activation was assessed. As predicted, the Pro680His dominant negative replacement completely abolished NF-kappaB activation (Figure 2). The truncated TLR6 variants (Leu251stop and codon 460/461-5 bp deletion) and one of the TIR domain variants (Asn690Thr) were significantly impaired in their ability to induce NF-kappaB activation compared to wild-type TLR6 (Figure 2). The rare variant (Thr255Ile) characterized by a substitution in a region of the extracellular domain containing a cluster of rare polymorphisms (Figure 1), also had a significant decrease in NF-kappaB signaling (Figure 2).
###end p 32
###begin title 33
Altered NF-kappaB signal transduction by rare variants of TLR6.
###end title 33
###begin p 34
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 164 171 157 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 423 430 410 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 483 487 470 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 495 499 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 503 504 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 514 515 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
HEK 293 cells were transiently co-transfected with TLR2 and the indicated TLR6 variant expression plasmids, NF-kappaB reporter (firefly luciferase), and beta-actin Renilla luciferase plasmids. NF-kappaB activation in transfected cells was measured 24 hrs post transfection. The data shown are the mean +/- SD from 4 independent experiments expressed as the percent relative firefly luciferase activity (RLU) (normalized to Renilla luciferase activity) induced in cells co-expressing TLR2 and WT TLR6. * P<0.01; ** P<0.001 compared to TLR6 WT NF-kappaB activity.
###end p 34
###begin p 35
###xml 819 827 815 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001318-g002">Figure 2</xref>
###xml 396 402 <span type="species:ncbi:9606">humans</span>
###xml 407 418 <span type="species:ncbi:9598">chimpanzees</span>
###xml 519 524 <span type="species:ncbi:9606">human</span>
###xml 526 536 <span type="species:ncbi:9598">chimpanzee</span>
###xml 542 547 <span type="species:ncbi:10090">mouse</span>
TaqMan real-time RT-PCR analysis was used to verify that there was no significant difference in the transcript level from the various TLR6 constructs, indicating that the observed deficiencies in signaling were not due to differences in the level of gene expression from the constructs used (data not shown). Of note, Thr756 is one of two amino acids in the entire TIR region that varies between humans and chimpanzees, whereas the Asn690Thr replacement is located in a region of the molecule that is well conserved in human, chimpanzee, and mouse TLR6 (data not shown). These observations suggested that an amino acid replacement at Asn690 would have a more substantial detrimental effect on NF-kappaB signaling than variation located at Thr756. This prediction was borne out by the results of our functional studies (Figure 2).
###end p 35
###begin title 36
###xml 56 64 <span type="species:ncbi:9606">Children</span>
Linkage between the TLR1-248S Variant and TB Disease in Children
###end title 36
###begin p 37
###xml 710 711 710 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 722 729 722 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0001318-t003">Table 3</xref>
###xml 976 977 976 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 601 609 <span type="species:ncbi:9606">children</span>
To further assess the finding from the adult case-control study that TLR1 N248S and S602I were associated with TB disease susceptibility, a separate family-based study was conducted to evaluate the linkage between these two common variants and TB disease. Among the 99 families studied, 64 families with both parents available were informative for conventional transmission/disequilibrium test (TDT) analysis by having at least one parent who was heterozygous for N248S. A total of 99 transmissions of the A (Asn) or G (Ser) allele of the TLR1 248 codon occurred from heterozygous parents to affected children. The G allele was transmitted 61 times compared to 38 times for the A allele, a significant excess (P = 0.021) (Table 3). A total of 53 families with heterozygous parents of S602I were informative. We observed 83 transmissions of S602I T or G allele in these 53 families. The T allele was transmitted 44 times (53.0%) compared with 39 times of the G allele (47.0%) (P = 0.875). The results provided additional evidence supporting the association between N248S and increased TB disease. The lack of linkage between S602I and TB disease in this TDT study suggested that this variant might be less important in pediatric than adult TB susceptibility.
###end p 37
###begin title 38
TDT analysis of N248S and S602I in families with pediatric TB cases
###end title 38
###begin title 39
Discussion
###end title 39
###begin title 40
TLR Variants and Susceptibility to TB Disease
###end title 40
###begin p 41
###xml 262 266 262 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR1</italic>
###xml 399 400 399 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 465 469 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 626 630 626 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 657 667 657 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bos taurus</italic>
###xml 952 953 952 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1007 1008 1007 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1086 1087 1086 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1085 1087 1085 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">X<sup>2</sup></italic>
###xml 1096 1097 1096 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1137 1141 1137 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 104 111 <span type="species:ncbi:9606">patient</span>
###xml 196 204 <span type="species:ncbi:9606">patients</span>
###xml 389 397 <span type="species:ncbi:9606">children</span>
###xml 620 625 <span type="species:ncbi:9606">human</span>
###xml 657 667 <span type="species:ncbi:9913">Bos taurus</span>
###xml 825 830 <span type="species:ncbi:9606">human</span>
###xml 896 903 <span type="species:ncbi:9606">patient</span>
###xml 1056 1059 <span type="species:ncbi:9913">cow</span>
###xml 1148 1156 <span type="species:ncbi:9606">patients</span>
###xml 1376 1384 <span type="species:ncbi:9606">patients</span>
###xml 1560 1563 <span type="species:ncbi:1773">MTB</span>
###xml 1933 1938 <span type="species:ncbi:9606">human</span>
###xml 2008 2014 <span type="species:ncbi:9606">humans</span>
###xml 2019 2030 <span type="species:ncbi:9598">chimpanzees</span>
Several lines of evidence suggest that TLR variants confer enhanced susceptibility to TB disease in our patient sample. First, there was a significant increase in the frequency of rare NSPs in TB patients compared to the matched controls. Second, in the case of TLR1, the TDT analysis revealed that the allele encoding the TLR-248S variant was significantly overrepresented among diseased children (P = 0.021). Third, cell biology studies found that several of the TLR6 variants were deficient in ability to mediate signal transduction. A fourth line of evidence stems from the population genetics analysis. By aligning human TLR6 coding sequences with the Bos taurus homolog (NM_001001159.1), we find that there were 167 nonsynonymous differences and 193 synonymous differences. These numbers vary somewhat depending on the human allele one uses, but the conclusion is robust to this choice-the patient sample has an excess of nonsynonymous variants (n = 24) relative to the number of synonymous variants (n = 9) compared to the degree of divergence with cow (McDonald-Kreitman test, X2 = 8.39, P<0.004). The pattern of polymorphism in TLR6 in TB patients deviated significantly from neutrality, and the major cause was an excess of rare mutations that would alter the primary amino acid sequence of TLR6. Inasmuch as singleton mutations occurred in significant excess in TB patients, the increase in susceptibility to TB disease associated with these polymorphisms must be substantial. In this regard, we note that before the introduction of widespread anti-MTB drug therapy in the 1950's, the death rate from TB was very high. Hence, the data are broadly consistent with a process whereby variants that reduce the ability to fight infections enter the population by mutation, but have been maintained at a low frequency by the action of natural selection. This process leads to an excess of rare nonsynonymous polymorphism in the human population compared to the number of nonsynonymous fixations between humans and chimpanzees.
###end p 41
###begin p 42
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Morris1">[42]</xref>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 495 503 495 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001318.s004">Table S3</xref>
###xml 508 517 508 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001318.s001">Figure S1</xref>
###xml 558 562 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Hudson1">[43]</xref>
###xml 629 633 629 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 953 957 953 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 1225 1229 1225 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 330 338 <span type="species:ncbi:9606">patients</span>
###xml 417 425 <span type="species:ncbi:9606">patients</span>
Haplotype analysis can be more powerful than SNP analysis for providing insight into the genetic basis of complex traits [42], and provides a fifth line of evidence for the role of TLR polymorphism in TB susceptibility. We found that both rare SNPs and rare haplotypes of TLR6 also were significantly overrepresented among the TB patients relative to the matched control population. The rare haplotypes present in TB patients do not cluster closely together in the phylogenetic network of TLR6 (Table S3 and Figure S1). Simulations of the neutral coalescent [43], with each sample of size 1,312 having 31 segregating sites (like TLR6) were performed to ask how often a random partition into 894 cases and 418 controls would produce a more extreme association with rare alleles in the case group by chance. This test found that only 3 out of 1000 samples had more than the observed number of singletons present in the group of cases than was observed in TLR6. The data appear to be consistent with the rare haplotypes being derived independently (and by their rarity, we infer recently) from multiple common haplotypes by single genetic events such as nucleotide substitution or deletion of a short segment of DNA. Insofar as TLR6 is concerned, this means that TB disease is not associated with a single unique mutation, rather, many independent mutations are associated with enhanced disease susceptibility.
###end p 42
###begin p 43
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Stead1">[44]</xref>
###xml 774 789 774 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 836 840 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Ferwerda1">[45]</xref>
###xml 774 789 <span type="species:ncbi:1773">M. tuberculosis</span>
Our findings may bear on a report in the literature suggesting that African Americans may have an enhanced susceptibility to TB disease [44]. We found significant association between common and rare NSPs and increased susceptibility to TB disease in African Americans. The TDT analysis also revealed an association between TLR1 and TB susceptibility. However, these findings were not uniformly the case in the European American and Hispanic populations. It is reasonable to consider what factors may account for the differences between populations. On average, these three populations have quite different recent ancestral histories, which means that they have undoubtedly encountered distinct selective forces, including but not limited to lethal infectious agents such as M. tuberculosis. In this regard, we note that Ferwerda et al. [45] recently have hypothesized that certain nonsynonymous amino acid changes polymorphisms in TLR4 rose to high frequency in sub-Saharan Africa because they protect against malaria.
###end p 43
###begin p 44
###xml 1158 1162 1158 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Jin1">[46]</xref>
Simply because of their rarity, individual rare variants are not shared across populations, adding to the apparent heterogeneity across population samples in TLR associations. It is very possible that some rare variants increase and some decrease susceptibility to TB. Given that the long-term effective population size of African Americans is larger than the other two populations we studied, one would expect more rare variants to occur in that population. Although several environmental factors are likely operative, and many genes contribute to TB susceptibility, a larger pool of rare variants (in either TLRs or other proteins) could be a factor contributing to an enhanced susceptibility to TB. We note that different selection pressures may also account for the reciprocal allele frequencies at the common variant sites (for example, TLR1-248 and TLR1-602) observed in the African American and European American populations. We also note that several of the amino acid polymorphisms we identified in TLR1 and TLR2 map to regions of these proteins that interact with each other and with lipopeptide, as recently revealed by crystal structure analysis [46].
###end p 44
###begin title 45
Detrimentally Altered Signal-Transduction by Rare Variants of TLR6 and TB Disease Susceptibility
###end title 45
###begin p 46
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Ozinsky1">[40]</xref>
###xml 498 503 498 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 505 509 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Bulut1">[47]</xref>
###xml 977 981 977 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Akira1">[15]</xref>
###xml 1332 1336 1332 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 153 156 <span type="species:ncbi:1773">MTB</span>
###xml 487 490 <span type="species:ncbi:1773">MTB</span>
###xml 556 561 <span type="species:ncbi:10090">mouse</span>
###xml 761 769 <span type="species:ncbi:9606">patients</span>
###xml 1077 1080 <span type="species:ncbi:1773">MTB</span>
###xml 1299 1307 <span type="species:ncbi:9606">patients</span>
Whether an individual develops TB disease or remains asymptomatic after exposure to the bacterium depends on the ability of the host to effectively kill MTB or sufficiently control its replication. Members of the TLR family of proteins recognize ligands derived from a variety of pathogens and trigger crucial steps in the protective immune response against infectious agents. TLR6 forms a heterodimeric complex with TLR2 to activate macrophages [40], a critical step in defense against MTB. Bulut et al. [47] reported that the dominant-negative mutant of mouse TLR6 (Pro691His) inhibited the ability of transfected cells to respond to soluble tuberculosis factor. Hence, it is reasonable to conclude that some of the rare TLR6 variants we identified in the TB patients have altered function. Indeed, the results of our cell biology studies, which focused on the formation of a functional TLR2/TLR6 signaling complex, confirmed this idea. Under a current model of TLR function [15], the proinflammatory signal-transduction cascade that protects the host from disease caused by MTB may be detrimentally altered in individuals with rare TLR6 variants, thereby leading to enhanced likelihood of clinical disease. Studies are underway to examine this issue in the context of primary cells obtained from patients and controls with known TLR6 genotypes.
###end p 46
###begin title 47
###xml 38 43 <span type="species:ncbi:9606">Human</span>
Rare Variants of Proteins Involved in Human Innate Immune Function and Infectious Disease Susceptibility
###end title 47
###begin p 48
###xml 92 95 92 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Casanova1">[4]</xref>
###xml 97 100 97 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Bellamy1">[5]</xref>
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Weiss1">[48]</xref>
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Wright1">[49]</xref>
###xml 653 657 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Cohen1">[50]</xref>
###xml 658 662 658 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Topal1">[52]</xref>
###xml 1211 1221 1208 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella</italic>
###xml 1228 1243 1225 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 1280 1284 1277 1281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-LichtenauerKaligis1">[53]</xref>
###xml 1285 1289 1282 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Fieschi1">[55]</xref>
###xml 1402 1406 1399 1403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Heyworth1">[56]</xref>
###xml 1554 1559 1551 1556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1561 1565 1558 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Picard1">[57]</xref>
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 136 141 <span type="species:ncbi:9606">human</span>
###xml 1228 1243 <span type="species:ncbi:1773">M. tuberculosis</span>
It is generally accepted that human susceptibility to TB disease is a complex genetic trait [4], [5]. Substantial controversy exists in human medical genetics regarding the contribution of common and rare mutations to susceptibility to complex diseases [48], [49]. One school of thought favors the idea that common genetic diseases are associated with polymorphisms that are present in relatively high frequency in a population (common disease/common variant model). Another school of thought argues that rare mutations play a much more important role in susceptibility to common diseases than usually assumed, and interest in this area is accelerating [50]-[52]. The results of our study support both arguments. While we do find common variants that display significant association with TB susceptibility, we also present evidence that rare variants of proteins that detrimentally alter innate host defense are important contributors to the outcome of the interaction between a bacterial pathogen and the infected individual. This theme is echoed by the finding that a large array of distinct rare variants of the IL-12 receptor beta1 result in enhanced susceptibility to infections caused by bacteria such as Salmonella spp., M. tuberculosis BCG, and environmental mycobacteria [53]-[55]. Moreover, we note that well over 200 otherwise rare mutations can cause X-linked chronic granulomatous disease [56], an abnormality characterized by altered ability of polymorphonuclear leukocytes to kill several bacterial and fungal pathogens. Similarly, Picard et al. [57] recently reported the occurrence of rare mutations in IRAK-4 that confer susceptibility to pyogenic bacterial infections.
###end p 48
###begin p 49
###xml 162 165 162 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Casanova1">[4]</xref>
###xml 167 170 167 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Bellamy1">[5]</xref>
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 140 148 <span type="species:ncbi:9606">patients</span>
Thus far, human TB susceptibility studies have been conducted largely by association studies that examine the effect of common mutations in patients and controls [4], [5]. One important practical consequence of the involvement of many distinct rare variants in host defense is that it likely will be necessary to completely sequence candidate susceptibility genes in large samples of affected individuals and control subjects to identify disease association.
###end p 49
###begin p 50
###xml 652 655 652 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Casanova1">[4]</xref>
###xml 657 660 657 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Bellamy1">[5]</xref>
###xml 662 666 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Kramnik1">[58]</xref>
###xml 1251 1255 1251 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Sreevatsan1">[59]</xref>
###xml 1256 1260 1256 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Gutacker1">[62]</xref>
###xml 1351 1355 1351 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Manca1">[63]</xref>
###xml 243 248 <span type="species:ncbi:9606">human</span>
###xml 513 521 <span type="species:ncbi:9606">patients</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
###xml 645 651 <span type="species:ncbi:9606">humans</span>
###xml 683 689 <span type="species:ncbi:9606">humans</span>
###xml 959 962 <span type="species:ncbi:1773">MTB</span>
###xml 982 987 <span type="species:ncbi:9606">human</span>
###xml 1032 1035 <span type="species:ncbi:1773">MTB</span>
###xml 1453 1456 <span type="species:ncbi:1773">MTB</span>
###xml 1542 1545 <span type="species:ncbi:1773">MTB</span>
###xml 1641 1646 <span type="species:ncbi:9606">human</span>
###xml 1762 1767 <span type="species:ncbi:9606">human</span>
###xml 1911 1916 <span type="species:ncbi:9606">human</span>
In summary, by discovering a link between TLR variants, altered TLR signal transduction, and enhanced susceptibility to TB disease, our findings provide strong impetus to analyze the relationship between nucleotide sequence variation in other human candidate genes, and susceptibility to infectious agents. Our study was designed to investigate the association of TLR variants with TB disease in only one geographic area that was purposely defined narrowly. Our findings may not be generally applicable to all TB patients. Indeed, there is substantial variance in the results of TB susceptibility studies reported in the literature for mice and humans [4], [5], [58]. In the case of humans, this variance may be caused by differences in ethnicity, environmental factors such as nutrition, and exposure to nontuberculous mycobacteria. Another variable that may, in principle, influence host-pathogen interaction is the relative frequency of distinct clones of MTB circulating in the human population under study. Although strains of MTB are, on average, relatively closely related in overall chromosomal character, many strain-to-strain genetic differences have been described, and the frequency of occurrence of distinct clones differs geographically [59]-[62]. In addition, evidence is accumulating that strains can differ significantly in virulence [63]. The possibility that different host genotypes have differential susceptibility across different MTB strains remains to be tested. It is a formal possibility that the mechanisms used by MTB strains to overcome host immunity differ in a strain-dependent fashion, or differ depending on human genotype/strain genotype combination. Clearly, studies analogous to the one we report here need to be conducted in human populations that differ in ethnicity and age from the one we investigated. It is also reasonable to speculate that rare TLR variants influence human susceptibility to disease caused by other infectious agents.
###end p 50
###begin title 51
Materials and Methods
###end title 51
###begin title 52
Population-Based Adult Case-Control Study
###end title 52
###begin p 53
###xml 135 138 135 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Ma1">[7]</xref>
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Ma2">[64]</xref>
###xml 156 157 156 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 42 45 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 146 154 <span type="species:ncbi:9606">Patients</span>
###xml 456 464 <span type="species:ncbi:9606">patients</span>
###xml 491 494 <span type="species:ncbi:1773">MTB</span>
###xml 887 895 <span type="species:ncbi:9606">Patients</span>
###xml 987 995 <span type="species:ncbi:9606">patients</span>
This study was based on analysis of 1,312 HIV-seronegative adults living in Houston, Texas, enrolled in a population-based study of TB [7], [64]. Patients (n = 894) with TB disease included 339 African Americans (mean age+/-SD, 46.5+/-12.8; male, 68.7%; extrapulmonary TB, 15.6%), 180 European Americans (mean+/-SD, 51.7+/-13.6; male, 75.0%; extrapulmonary TB, 11.1%), and 375 Hispanics (mean+/-SD, 42.3+/-17.2; male, 63.5%; extrapulmonary TB, 14.7%). All patients were identified by either MTB culture positivity (92.8%) or clinical improvement (7.2%) in response to antimycobacterial treatment without a history of immunosuppressive condition. Extra-pulmonary TB was defined as involvement of an extrathoracic site, or the thoracic pleura or lymph nodes according to the official statement of the American Thoracic Society and the Centers for the Disease Control and Prevention (CDC). Patients with both pulmonary and extra-pulmonary TB were classified as extra-pulmonary. None of the patients were known to be genetically related.
###end p 53
###begin p 54
###xml 20 21 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 377 384 <span type="species:ncbi:9606">patient</span>
###xml 690 702 <span type="species:ncbi:9606">participants</span>
The control sample (n = 418) consisted of 194 African Americans (mean+/-SD, 45.5+/-10.6; male, 75.8%), 110 European Americans (mean age+/-SD, 50.0+/-10.0; male, 67.3%) and 114 Hispanics (mean age+/-SD, 43.4+/-11.0; male, 58.8%) without a history of TB disease, autoimmune diseases, and other infectious diseases. These individuals either lived in the same neighborhood as a TB patient or were health care workers. All control subjects were followed for at least 6 months to confirm their clinical status. In this study, ethnicity was determined by self-identification. European Americans were defined as non-Hispanic, white individuals. Written informed consent was obtained from all study participants for the studies performed herein. The study was approved by the Institutional Review Board at Baylor College of Medicine.
###end p 54
###begin p 55
Cut-off lines used for rare and common polymorphisms are usually 1% to 5% depending on the study. We used 3% as a cut-off value because the sample sizes in our adult case-control study ranged from 110 to 375 in different ethnic groups of cases and controls. If a SNP had an allele frequency of 3% in one ethnic group, it will have at least 6.6 alleles in the smallest group having 110 individuals (e.g. European American controls). This is statistically feasible for a 2x2 Chi-square test.
###end p 55
###begin title 56
###xml 62 70 <span type="species:ncbi:9606">Children</span>
Transmission/Disequilibrium Test (TDT) within the Families of Children with TB
###end title 56
###begin p 57
###xml 300 305 <span type="species:ncbi:9606">child</span>
To avoid potential bias in the adult case-control study caused by population substructures or control selection, a separate family-based association study using TDT was conducted to provide additional support for the detected TLR1 variant associations. Ninety-nine nuclear families consisting of one child with TB and two biological parents from the greater Houston area were studied.
###end p 57
###begin title 58
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
Sequencing of TLR Genes
###end title 58
###begin p 59
###xml 164 167 164 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR</italic>
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR1</italic>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR2</italic>
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR10</italic>
###xml 332 340 332 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001318.s005">Table S4</xref>
Genomic DNA was prepared from peripheral blood leukocytes by standard phenol-chloroform extraction methods. Full-coding region sequencing was conducted on all five TLR genes (TLR1, TLR2, TLR4, TLR6, and TLR10) in the 1,312 subjects. PCR products used for sequencing were obtained by amplifying genomic DNA with the primers shown in Table S4. DNA sequencing was conducted with an ABI 3730 instrument. The software used for initial data analysis was Sequencher (Gene Codes, Ann Arbor, MI). All raw data were assembled and analyzed by two individuals independently and blinded to the analyses performed by the other. The data were compared, and the few discrepancies were resolved. This procedure, although tedious, resulted in a data set of unusually high quality.
###end p 59
###begin title 60
Statistical Analysis of the Adult Subject Data
###end title 60
###begin p 61
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Pritchard1">[65]</xref>
###xml 498 499 498 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 564 568 564 568 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">corr</sub>
###xml 563 568 563 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P<sub>corr</sub></italic>
###xml 577 578 577 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 579 580 579 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</sup>
###xml 587 588 587 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 611 612 611 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 657 661 657 661 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">corr</sub>
###xml 656 661 656 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P<sub>corr</sub></italic>
Within each ethnic grouping, the 179 SNP genotypes were examined for hidden population subdivision using the program STRUCTURE 2.2 [65]. Seeing no evidence for latent structure, Hardy Weinberg tests were performed for each SNP that presented 3 genotypic classes. The homogeneity of frequencies of genotypes between the cases and controls in each ethnic group were tested by using a Chi-square test for two-by-two and two-by-three contingency tables with SAS (version 8.0, SAS Institute; Cary, NC). P-values were corrected for multiple comparisons by the formula (Pcorr = 1- [1-P]n, with P being the uncorrected P value, and n the number of comparisons). A Pcorr less than 0.05 was considered to be statistically significant. The significant tests reported here were also significant by standard Bonferroni correction.
###end p 61
###begin title 62
Plasmid Constructs and Site-Directed Mutagenesis
###end title 62
###begin p 63
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 77 86 77 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001318.s001">Figure S1</xref>
###xml 91 99 91 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001318.s004">Table S3</xref>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 513 517 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Takeuchi1">[41]</xref>
###xml 519 522 519 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spe</italic>
###xml 599 603 599 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 711 715 711 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 738 747 738 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001318.s001">Figure S1</xref>
###xml 878 881 878 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spe</italic>
###xml 900 904 900 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 991 994 991 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Age</italic>
###xml 1000 1003 1000 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nhe</italic>
###xml 1085 1089 1085 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 1180 1187 1177 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 1467 1471 1460 1464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Chang1">[31]</xref>
###xml 1473 1477 1466 1470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001318-Omueti1">[33]</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 448 453 <span type="species:ncbi:10090">mouse</span>
###xml 1389 1394 <span type="species:ncbi:9606">human</span>
The reference allele and the most common allele of human TLR6, haplotype h2 (Figure S1 and Table S3), were amplified from genomic DNA and cloned into pCR-XL-TOPO (Invitrogen, Carlsbad, CA). Rare allelic variants of TLR6 and the allele of TLR6 encoding a dominant-negative form (Pro680His) of the receptor were made using the QuickChange Multi Site-Directed Mutagenesis system (Stratagene, La Jolla, CA). The analogous dominant negative mutation in mouse TLR6 (Pro691His) was reported and characterized previously [41]. SpeI restriction fragments made from the pCR-TOPO-XL-TLR6 clones containing the TLR6 allelic variants were subcloned into the pUNO-hTLR6 cDNA expression vector (InvivoGen, San Diego, CA). The TLR6 allelic variant, h19 (Figure S1), characterized by a 5 bp deletion at codon 460 and 461, had additional common polymorphisms of which one occurred outside of the SpeI sites. Thus, the TLR6 gene for the 5 bp deletion variant was amplified from genomic DNA and cloned into the AgeI and NheI sites of pUNO-hTLR6. All constructs were verified by sequencing of the complete TLR6 with an ABI PRISM 3700 DNA Analyzer (Applied Biosystems, Foster City, CA). The beta-actin-Renilla luciferase construct used as a transfection control was generously provided by C.B. Wilson and A.M. Hajjar, University of Washington. The NF-kappaB reporter plasmid, ELAM-1-firefly luciferase, and the human TLR2 cDNA expression construct, gD.TLR2, have been described previously [31], [33].
###end p 63
###begin title 64
Cell Culture, Transfections, and Dual Luciferase Reporter Assays
###end title 64
###begin p 65
###xml 161 162 155 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 359 360 352 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 467 471 459 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR6</italic>
###xml 588 595 570 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 267 273 <span type="species:ncbi:9913">bovine</span>
The human embryonic kidney (HEK) 293 cell line (CRL-1573) was purchased from the American Type Culture Collection (Manassas, VA) and grown at 37degreesC in 5% CO2 in DMEM medium supplemented with 10 mM HEPES, 100 IU penicillin, 100 mug streptomycin/ml, and 10% fetal bovine serum (Invitrogen, Carlsbad, CA). HEK 293 cells were seeded into 24-well plates (1x105 cells/well) the day before transfection. Cells were transiently transfected with 0.3 mug of the specified TLR6 expression construct and 0.006 mug of plasmid gD.TLR2, 0.091 mug of NF-kappaB reporter, and 0.003 mug of beta-actin-Renilla luciferase plasmid. Transfections were performed using FuGene 6 transfection reagent (Roche, Indianapolis, IN) as recommended by the manufacturer. Twenty-four hours post transfection, cell lysates were prepared and luciferase activity for each reporter construct was determined using the Dual-Luciferase Reporter assay system (Promega, Madison, WI) following the manufacturer's specifications.
###end p 65
###begin title 66
Supporting Information
###end title 66
###begin p 67
###xml 397 405 397 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001318.s004">Table S3</xref>
###xml 475 485 <span type="species:ncbi:9598">chimpanzee</span>
Haplotype analysis of TLR6 variants. Thirty-two haplotypes were identified or inferred based on the segregation sites in the coding region of TLR6. The reference sequence from the database (GenBank accession no. AB020807) was designated as h0. Six of 32 haplotypes were characterized by the presence of only 1 mutation, whereas the other 27 haplotypes were differentiated by at lease 2 mutations (Table S3). The haplotypes tend to cluster in two major clades, h0 and h2. The chimpanzee lineage was located between the two major clades, suggesting that h0 and h2 are probably quite ancient. Three cycles are present in the haplotype network (h2-h7-h10-h2; h2-h1-h6-h8-h2; h2-h22-chimp-h2), suggesting that intragenic recombination or repeated mutation occurred in the evolutionary history of TLR6.
###end p 67
###begin p 68
(1.17 MB TIF)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin p 70
###xml 20 25 <span type="species:ncbi:9606">human</span>
Genetic variants in human TLR1, 2, 4, 6, 10 genes
###end p 70
###begin p 71
(0.10 MB PDF)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
Associations between common nonsynonymous variants of TLR1, 4, 6, 10 genes with TB and Extrapulmonary TB (EPTB) disease
###end p 73
###begin p 74
(0.21 MB DOC)
###end p 74
###begin p 75
Click here for additional data file.
###end p 75
###begin p 76
Haplotype analysis of TLR6 genetic variants
###end p 76
###begin p 77
(0.04 MB PDF)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
Oligonucleotide primers used to amplify and sequence TLR1, 2, 4, 6, and 10
###end p 79
###begin p 80
(0.06 MB PDF)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
###xml 241 248 238 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla</italic>
###xml 157 164 <span type="species:ncbi:9606">patient</span>
We thank A. Gohel, X. Pan, R. A. Reich, L. Sherman, G. Sylva, and J. Wilson for assistance with DNA sequencing and data analysis, L. D. Teeter for help with patient information, and C. B. Wilson and A. M. Hajjar for providing the beta-actin-Renilla luciferase construct.
###end p 82
###begin title 83
References
###end title 83
###begin article-title 84
Twin studies on the significance of genetic factors in tuberculosis.
###end article-title 84
###begin article-title 85
Tuberculosis in twins: a re-analysis of the Prophit survey.
###end article-title 85
###begin article-title 86
###xml 52 57 <span type="species:ncbi:9606">human</span>
Genetic dissection of immunity to mycobacteria: the human model.
###end article-title 86
###begin article-title 87
Susceptibility to mycobacterial infections: the importance of host genetics.
###end article-title 87
###begin article-title 88
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human genetics of common mycobacterial infections.
###end article-title 88
###begin article-title 89
###xml 51 56 <span type="species:ncbi:9606">human</span>
Association between interleukin-8 gene alleles and human susceptibility to tuberculosis disease.
###end article-title 89
###begin article-title 90
Alleles of the NRAMP1 gene are risk factors for pediatric tuberculosis disease.
###end article-title 90
###begin article-title 91
A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis.
###end article-title 91
###begin article-title 92
Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis.
###end article-title 92
###begin article-title 93
Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa.
###end article-title 93
###begin article-title 94
A polymorphism in toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis.
###end article-title 94
###begin article-title 95
###xml 18 23 <span type="species:ncbi:9606">human</span>
A polymorphism in human TLR2 is associated with increased susceptibility to tuberculosis meningitis.
###end article-title 95
###begin article-title 96
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria, and tuberculosis.
###end article-title 96
###begin article-title 97
Pathogen recognition and innate immunity.
###end article-title 97
###begin article-title 98
###xml 80 91 80 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia</italic>
###xml 96 106 96 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Salmonella</italic>
###xml 80 91 <span type="species:ncbi:562">Escherichia</span>
Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides.
###end article-title 98
###begin article-title 99
###xml 67 73 <span type="species:ncbi:9606">humans</span>
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans.
###end article-title 99
###begin article-title 100
Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility.
###end article-title 100
###begin article-title 101
A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease.
###end article-title 101
###begin article-title 102
Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease.
###end article-title 102
###begin article-title 103
A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy.
###end article-title 103
###begin article-title 104
Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages.
###end article-title 104
###begin article-title 105
###xml 57 83 57 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 57 83 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis.
###end article-title 105
###begin article-title 106
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors.
###end article-title 106
###begin article-title 107
###xml 63 89 63 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 63 89 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice.
###end article-title 107
###begin article-title 108
###xml 121 147 121 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 121 147 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis.
###end article-title 108
###begin article-title 109
###xml 11 37 11 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 11 37 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2.
###end article-title 109
###begin article-title 110
###xml 47 73 47 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 47 73 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection.
###end article-title 110
###begin article-title 111
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Mycobacterium tuberculosis regulates CD1 antigen presentation pathways through TLR-2.
###end article-title 111
###begin article-title 112
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Toll-like receptor 4 plays a protective role in pulmonary tuberculosis in mice.
###end article-title 112
###begin article-title 113
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
Mycobacterium tuberculosis induces selective up-regulation of TLRs in the mononuclear leukocytes of patients with active pulmonary tuberculosis.
###end article-title 113
###begin article-title 114
Genomic variants of TLR1-it takes (TLR-)two to tango.
###end article-title 114
###begin article-title 115
###xml 26 31 <span type="species:ncbi:9606">human</span>
The polymorphism P315L of human toll-like receptor 1 impairs innate immune sensing of microbial cell wall components.
###end article-title 115
###begin article-title 116
###xml 9 14 <span type="species:ncbi:9606">human</span>
A common human TLR1 polymorphism regulates the innate immune response to lipopeptides.
###end article-title 116
###begin article-title 117
Dendritic cell maturation induced by muramyl dipeptide (MDP) derivatives: monoacylated MDP confers TLR2/TLR4 activation.
###end article-title 117
###begin article-title 118
###xml 34 39 <span type="species:ncbi:9606">human</span>
The Arg753Gln polymorphism of the human toll-like receptor 2 gene in tuberculosis disease.
###end article-title 118
###begin article-title 119
###xml 106 114 <span type="species:ncbi:9606">patients</span>
Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients.
###end article-title 119
###begin article-title 120
###xml 19 24 <span type="species:ncbi:9606">human</span>
Global patterns of human DNA sequence variation in a 10-kb region on chromosome 1.
###end article-title 120
###begin article-title 121
The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia.
###end article-title 121
###begin article-title 122
The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors.
###end article-title 122
###begin article-title 123
Discrimination of bacterial lipoproteins by Toll-like receptor 6.
###end article-title 123
###begin article-title 124
On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles.
###end article-title 124
###begin article-title 125
Generating samples under a Wright-Fisher neutral model of genetic variation.
###end article-title 125
###begin article-title 126
###xml 53 79 53 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 53 79 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Racial differences in susceptibility to infection by Mycobacterium tuberculosis.
###end article-title 126
###begin article-title 127
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TLR4</italic>
###xml 94 100 <span type="species:ncbi:9606">humans</span>
TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans.
###end article-title 127
###begin article-title 128
Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide.
###end article-title 128
###begin article-title 129
###xml 101 121 101 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Borrelia burgdorferi</italic>
###xml 101 121 <span type="species:ncbi:139">Borrelia burgdorferi</span>
Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling.
###end article-title 129
###begin article-title 130
How many diseases does it take to map a gene with SNPs?
###end article-title 130
###begin article-title 131
Complex genetic diseases: controversy over the Croesus code.
###end article-title 131
###begin article-title 132
Multiple rare alleles contribute to low plasma levels of HDL cholesterol.
###end article-title 132
###begin article-title 133
Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.
###end article-title 133
###begin article-title 134
The resequencing imperative.
###end article-title 134
###begin article-title 135
###xml 7 26 7 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium bovis</italic>
###xml 7 30 <span type="species:ncbi:33892">Mycobacterium bovis BCG</span>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta1 deficient patients and evidence for the existence of partial IL-12 receptor beta1 deficiency.
###end article-title 135
###begin article-title 136
Influence of interleukin-12 receptor beta1 polymorphisms on tuberculosis.
###end article-title 136
###begin article-title 137
Low penetrance, broad resistance, and favorable outcome of interleukin-12 receptor beta1 deficiency: medical and immunological implications.
###end article-title 137
###begin article-title 138
Hematologically important mutations: X-linked chronic granulomatous disease (second update).
###end article-title 138
###begin article-title 139
###xml 33 39 <span type="species:ncbi:9606">humans</span>
Pyogenic bacterial infections in humans with IRAK-4 deficiency.
###end article-title 139
###begin article-title 140
Immunity to intracellular pathogens as a complex genetic trait.
###end article-title 140
###begin article-title 141
###xml 47 73 47 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 47 81 <span type="species:ncbi:77643">Mycobacterium tuberculosis complex</span>
Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination.
###end article-title 141
###begin article-title 142
###xml 32 58 32 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 32 58 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Negligible genetic diversity of Mycobacterium tuberculosis host immune system protein targets: evidence of limited selective pressure.
###end article-title 142
###begin article-title 143
###xml 23 49 23 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 23 49 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Global distribution of Mycobacterium tuberculosis spoligotypes.
###end article-title 143
###begin article-title 144
###xml 68 94 68 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 68 94 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites.
###end article-title 144
###begin article-title 145
###xml 15 41 15 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 15 41 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta.
###end article-title 145
###begin article-title 146
###xml 97 105 <span type="species:ncbi:9606">patients</span>
5' dinucleotide repeat polymorphism of NRAMP1 and susceptibility to tuberculosis among Caucasian patients in Houston, Texas.
###end article-title 146
###begin article-title 147
Inference of population structure using multilocus genotype data.
###end article-title 147
###begin p 148
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 148
###begin p 149
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institute of Health
###end p 149

